TYRA · Company research

Tyra Biosciences, Inc. Common Stock (TYRA): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 202620.24$1,450,485,938.581376650938.58————4.1013106750475027—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.